How cost-effective is breast cancer screening in different EC countries?

European Journal of Cancer

Volumn 29, Issue 12, 1993, Pages 1663-1668

  van Ineveld, B Martin ^a   van Oortmarssen, Gerrit J ^a   de Koning, Harry J ^a   Boer, Rob ^a   van der Maas, Paul J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; COMPARATIVE STUDY; COST-BENEFIT ANALYSIS; FEMALE; FRANCE; GREAT BRITAIN; HUMAN; LIFE EXPECTANCY; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGE; NETHERLANDS; SPAIN;

EID: 0027313185     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(93)90100-T     Document Type: Article

References (27)

1. Evaluation of screening for breast cancer in a non-randomized study (the DOM project) by means of a case-control study
2. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975–1981
3. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.
4. First results on mortality reduction in the UK trial of Early Detection of Breast Cancer
5. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial
6. Edinburgh trial of screening for breast cancer: mortality at seven years
7. Chapter IV. Reduced breast-cancer mortality with mammography screening-an assessment of currently available data
8. Breast Cancer Screening
9. Breast cancer screening and cost-effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factors
10. Cancer in the European community and its member states
11. The cost-effectiveness of breast cancer screening
12. Is the supply of mammography machines outstripping need and demand?
13. A simulation approach to cost-effectiveness and cost-benefit calculations of screening for early detection of disease
14. A model for breast cancer screening
15. Breast cancer screening: its impact on clinical medicine
16. Advanced breast cancer and its prevention by screening
17. Preventive Pap-smears: balancing costs, risks and benefits
18. Changing patterns in the presentation of breast cancer over 25 years
19. Specificity of screening in United Kingdom trial of early detection of breast cancer.
20. Observations on mammographic screening and false-positive mammograms